2024-01-24T06:38:38-06:00 2021-12-31 541029635 THOMPSON GREENSPON 4035 RIDGE TOP RD SUITE 700 FAIRFAX VA 22030 990 2021-01-01 061548706 AMERICAN THORACIC SOCIETY INC AMER 2123158600 25 BROADWAY 4TH FLOOR NEW YORK NY 10004 PATRICIA HUIE CHIEF FINANCIAL OFFICER 2123158600 2022-11-14 1 PATRICIA HUIE 999009999 TRACY M MOREY CPA P01521539 7033858888 3 AAL1 IAL1 2021 2023-04-26 12:10:37Z X PATRICIA HUIE 25 BROADWAY 4TH FLOOR NEW YORK NY 10004 33449150 0 X WWW.THORACIC.ORG X 2001 DC THE MISSION OF ATS IS TO IMPROVE HEALTH WORLDWIDE BY ADVANCING RESEARCH, CLINICAL CARE, AND PUBLIC HEALTH IN RESPIRATORY DISEASE, CRITICAL ILLNESS, AND SLEEP DISORDERS. THE MEDICAL AND SCIENTIFIC AREAS OF INTEREST ARE AS FOLLOWS: PULMONOLOGY, CRITICAL CARE, SLEEP MEDICINE, INFECTIOUS DISEASE, PEDIATRICS, ALLERGY/IMMUNOLOGY, THORACIC SURGERY, BEHAVIORAL SCIENCE, ENVIRONMENTAL AND OCCUPATIONAL MEDICINE, PHYSIOLOGY AND MOLECULAR BIOLOGY. 27 26 113 39 1772769 906723 12207341 2324764 12315478 17747357 1569734 1240906 4894224 1141445 30986777 22454472 550150 1516515 0 0 13069397 12969749 0 0 883995 12255927 11032276 25875474 25518540 5111303 -3064068 47033296 49419449 15039430 17957479 31993866 31461970 X AMERICAN THORACIC SOCIETY, INC. IS AN INTERNATIONAL PROFESSIONAL AND SCIENTIFIC SOCIETY WHICH PREVENTS AND FIGHTS RESPIRATORY DISEASE THROUGH RESEARCH, EDUCATION, PATIENT CARE AND ADVOCACY. THE MISSION OF ATS IS TO IMPROVE HEALTH WORLDWIDE BY ADVANCING RESEARCH, CLINICAL CARE, AND PUBLIC HEALTH IN RESPIRATORY DISEASE, CRITICAL ILLNESS, AND SLEEP DISORDERS. THE MEDICAL AND SCIENTIFIC AREAS OF INTEREST ARE AS FOLLOWS: PULMONOLOGY, CRITICAL CARE, SLEEP MEDICINE, INFECTIOUS DISEASE, PEDIATRICS, ALLERGY/IMMUNOLOGY, THORACIC SURGERY, BEHAVIORAL SCIENCE, ENVIRONMENTAL AND OCCUPATIONAL MEDICINE, PHYSIOLOGY AND MOLECULAR BIOLOGY. 0 0 5152846 42718 6850076 INTERNATIONAL CONFERENCE - PROVIDES ORIGINAL RESEARCH AND EDUCATION IN RESPIRATORY AND CRITICAL CARE MEDICINE. ANNUALLY, THE ORGANIZATION HOLDS THE MOST PRESTIGIOUS RESPIRATORY AND CRITICAL CARE CONFERENCE OFFERING PROGRAMS FOR PHYSICIANS, SCIENTISTS AND HEALTH CARE PROVIDERS ON TOPICS IN AREAS OF PULMONARY, RESPIRATORY, SLEEP, ENVIRONMENTAL/OCCUPATIONAL HEALTH AND CRITICAL CARE MEDICINE. THIS INTERNATIONAL CONFERENCE FEATURES SIX DAYS OF PROFESSIONAL EDUCATION AND THE OPPORTUNITY FOR A CRITICAL EXCHANGE OF INFORMATION BETWEEN PULMONARY AND CRITICAL CARE SLEEP SPECIALISTS AROUND THE WORLD. PRESENTATIONS OF ORIGINAL RESEARCH IN ALL RESPIRATORY FIELDS ARE REPRESENTED AND SPECIAL TRACKS IN CLINICAL MEDICINE AND CRITICAL CARE OFFER A FOCUSED PROGRAM FOR CLINICIANS AND OTHERS.AS WITH SO MANY OTHER EVENTS, THE 2021 MEETING WAS A HYBRID EVENT (IN-PERSON AND VIRTUAL). THE VIRTUAL CONFERENCE INCLUDED 65 SCIENTIFIC SYMPOSIA: 34 WERE PARTIALLY LIVE WITH Q&A. ATS PROGRAMMED 14 POST GRADUATE COURSES WITH LIVE Q&A AND 24 MEET THE EXPERT SEMINARS WITH LIVE Q&A. ADDITIONALLY, IN 2021, ATS PROGRAMMED OVER 3,959 ABSTRACTS. THE CONFERENCE HAD NEARLY 9,000 ATTENDEES. THE ATS ALSO HOSTED 14 VIRTUAL ASSEMBLY MEMBERSHIP MEETINGS THAT REACHED 3,750 AND 24 VIRTUAL MINI-SYMPOSIA WHICH REACHED 1,800 LIVE ATTENDEES. 4719748 498 5792601 EDUCATIONAL PUBLICATIONS - TO PUBLISH EDUCATIONAL JOURNALS ON RESPIRATORY DISEASES.1) AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (AJRCCM) - THIS OFFICIAL INTERNATIONAL, FLAGSHIP JOURNAL OF THE ORGANIZATION IS PUBLISHED TWICE MONTHLY AND FOCUSES ON HUMAN BIOLOGY AND DISEASE AS WELL AS STUDIES THAT CONTRIBUTE TO THE UNDERSTANDING OF THE PATHOPHYSIOLOGY AND TREATMENT OF DISEASES THAT AFFECT THE RESPIRATORY SYSTEM AND CRITICALLY ILL PATIENTS. THE JOURNAL PUBLISHES HIGH-QUALITY, ORIGINAL PAPERS, REVIEWS, AND CLINICAL TRIALS IN RESPIRATORY, CRITICAL CARE, AND SLEEP MEDICINE TO FOSTER ADVANCES IN TRANSLATIONAL RESEARCH AND CLINICAL PRACTICE. IMPACT FACTOR: 30.52.2) AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (AJRCMB) - AN OFFICIAL INTERNATIONAL JOURNAL OF THE ORGANIZATION, THIS MONTHLY PUBLICATION FOCUSES ON CELLULAR, BIOCHEMICAL, MOLECULAR, DEVELOPMENTAL GENETIC AND IMMUNOLOGIC STUDIES OF LUNG CELLS AND MOLECULES. THE JOURNAL PUBLISHES PAPERS THAT REPORT SIGNIFICANT AND ORIGINAL OBSERVATIONS IN THE AREA OF RESPIRATORY AND LUNG CELL BIOLOGY, INCLUDING CELLULAR, BIOCHEMICAL, MOLECULAR, DEVELOPMENTAL, GENETIC, AND IMMUNOLOGIC STUDIES IN HEALTH AND IN ACUTE AND CHRONIC DISORDERS RELATED TO THE RESPIRATORY SYSTEM AND SLEEP. IMPACT FACTOR: 7.743) THE ANNALS OF THE AMERICAN THORACIC SOCIETY IS AN OFFICIAL INTERNATIONAL, MONTHLY JOURNAL OF THE AMERICAN THORACIC SOCIETY. ANNALSATS DELIVERS UP-TO-DATE AND AUTHORITATIVE COVERAGE OF ADULT AND PEDIATRIC PULMONARY AND RESPIRATORY SLEEP MEDICINE AND ADULT MEDICAL CRITICAL CARE. THE SCOPE OF THE JOURNAL ENCOMPASSES CONTENT THAT IS APPLICABLE TO CLINICAL PRACTICE, THE FORMATIVE AND CONTINUING EDUCATION OF CLINICAL SPECIALISTS, AND THE ADVANCEMENT OF PUBLIC HEALTH. IMPACT FACTOR: 8.78.4) IN 2020, THE ATS LAUNCHED ATS SCHOLAR, AN OFFICIAL INTERNATIONAL JOURNAL OF AMERICAN THORACIC SOCIETY. ATS SCHOLAR IS A PEER-REVIEWED, ONLINE-ONLY, OPEN-ACCESS, EDUCATION-THEMED JOURNAL FOCUSING ON MEDICAL EDUCATION, CLINICAL EDUCATION, EDUCATION RESEARCH, AND QUALITY IMPROVEMENT. THE JOURNAL PUBLISHES PEER-REVIEWED HEALTH PROFESSIONS EDUCATION MANUSCRIPTS RELEVANT TO THE FIELDS OF PULMONARY, CRITICAL CARE AND SLEEP MEDICINE, INCLUDING THOSE RELATED TO THE TEACHING OF COMMON CLINICAL TOPICS, THE TRAINING OF HEALTHCARE PROVIDERS AND SCIENTISTS, AND EDUCATIONAL RESEARCH. ATS SCHOLAR IS INDEXED IN WEB OF SCIENCE, SCOPUS, AND PUBMED CENTRAL. ALWAYS A KEY CHANNEL FOR DISSEMINATION OF THE LATEST IN RESEARCH AND CLINICAL CARE, THE SOCIETY'S JOURNALS PLAY A KEY ROLE IN THE FIGHT AGAINST COVID-19. ALL COVID ARTICLES ARE AVAILABLE FREE OF CHARGE TO THE READERS. THE TOTAL IMPACT IS AS FOLLOWS:- PODCAST DOWNLOADS = APPROXIMATELY 158,364- VIDEO VIEWS = 63,240- ADDITIONAL COVID MANUSCRIPTS RECEIVED (INCLUDES ALL 4 JOURNALS): APPROXIMATELY 700 PROJECTED- FULL-ARTICLE DOWNLOADS/VIEWS (INCLUDES ALL 4 JOURNALS): APPROXIMATELY 14 MILLION PROJECTED 4237944 24614 779602 EDUCATION - TO PROVIDE EDUCATION FOR PULMONARY CRITICAL CARE AND SLEEP MEDICINE CLINICIANS, RESEARCHERS, ADVANCE PRACTICE NURSES AND OTHER HEALTH CARE PROFESSIONALS. THROUGHOUT THE YEAR, EDUCATIONAL OPPORTUNITIES ARE ALSO PROVIDED IN A VARIETY OF TEACHING MODALITIES, INCLUDING LIVE EVENTS, JOURNAL CLUBS, WEBINARS, PODCASTS, AND ONLINE LEARNING.SPECIAL AREAS OF FOCUS FOR 2021 INCLUDED: EARLY CAREER PROFESSIONAL (ECP) PROGRAMS: IN 2021, ALL ECP INITIATIVES TRANSITIONED TO VIRTUAL FORMATS UTILIZING FLIPPED CLASSROOM EDUCATIONAL MODELS AS WELL AS BREAKOUTS AND CASE-BASED LEARNING. THE EDUCATION TEAM HOSTED OVER 300 STUDENTS, RESIDENTS AND FELLOWS WITH WORKSHOPS, VIDEOS AND BREAKOUT SESSIONS. 2021 ATS CLINICAL CORE CURRICULUM SERIES: THIS STANDALONE SERIES FEATURED 4 SEPARATE MODULES IN PULMONARY, CRITICAL CARE, SLEEP MEDICINE AND PEDIATRICS AND WAS ACCREDITED FOR CME CREDITS AND MOC POINTS. ASSEMBLY-BASED ELEARNING ACTIVITIES INCLUDED NEARLY 450 MENTORING PROGRAM PARTICIPANTS, 85 CASE-BASED QUICK HITS REACHING MORE THAN 37,000 LEARNERS, EARLY CAREER NETWORKING EVENTS FOR 800+ PARTICIPANTS, PLUS APPROXIMATELY 70 JOURNAL CLUBS WITH 11,000 PARTICIPANTS.2021 ATS GUIDELINES IMPLEMENTATION WEBINAR SERIES: THIS CONTINUING MEDICAL EDUCATION (CME) DESIGNATED SERIES FEATURED FOUR SEPARATE WEBINARS ON IMPLEMENTATION OF RECENTLY APPROVED OR PUBLISHED CLINICAL PRACTICE GUIDELINES ON DURABLE MEDICAL EQUIPMENT, PULMONARY INFECTION, COPD, AND INFLAMMATORY LUNG DISEASE. 2021 CHAPTER CME: ATS SUPPORTED THE CME NEEDS OF FIVE ATS CHAPTERS HELD REGARDING VIRTUAL MEETING ACTIVITIES AND WORKED WITH THE CHAPTER LEADERSHIP TO DESIGNATE THE EDUCATIONAL OFFERINGS FOR CME.2021 GRANT SUPPORTED ACTIVITIES: WORKED WITH A MEDICAL EDUCATION PARTNER, AKH, INC., TO DEVELOP AND IMPLEMENT FOUR MULTIMODAL ACTIVITIES DESIGNATED FOR MULTIPLE TYPES OF CONTINUING EDUCATION CREDIT. 3200244 1448685 4387582 OTHER PROGRAMS CONSIST OF THE RESEARCH PROGRAM AND MEMBERSHIP SERVICES. 3200244 1448685 4387582 17310782 1 1 0 1 0 0 0 0 1 1 1 0 0 0 1 1 1 0 0 0 1 0 1 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 113 0 1 113 1 1 1 0 0 0 0 0 0 0 0 0 0 0 X 27 26 0 0 0 0 1 1 0 1 1 0 1 1 0 1 1 1 1 1 1 1 0 AL AK AZ AR CA CO CT DC FL GA HI IL IA KS KY LA ME MD MA MI MN MS MO MT NV NH NJ NM NY NC ND OH OK OR PA RI SC TN TX UT VA WA WV WI X X PATRICIA HUIE 2123158600 25 BROADWAY 4TH FLOOR NEW YORK NY 10004 ANDREW J HALAYKO CHAIR, IC COMMITTEE 2.00 X 17500 0 0 PATRICIA SIME ASSEMBLY CHAIR 2.00 X 4607 0 0 MIHAELA TEODORESCU ASSEMBLY CHAIR UNTIL 5/19 2.00 X 1768 0 0 REENA MEHRA ASSEMBLY CHAIR 2.00 X 1536 0 0 TISHA S WANG CHAIR, EDUCATION COMMITTEE 2.00 X 833 0 0 JUAN C CELEDON PRESIDENT & IMMEDIATE PAST PRESIDENT 7.00 X X 0 0 0 LYNN M SCHNAPP PRESIDENT ELECT & PRESIDENT 7.00 X X 0 0 0 GREGORY P DOWNEY VP & PRESIDENT ELECT 5.00 X X 0 0 0 M PATRICIA RIVERA SECRETARY-TREASURER & VP 5.00 X X 0 0 0 IRINA PETRACHE SECRETARY-TREASURER 5.00 X X 0 0 0 JAMES BECK PAST PRESIDENT UNTIL 5/19 5.00 X X 0 0 0 ANNA HEMNES ASSEMBLY CHAIR UNTIL 5/19 2.00 X 0 0 0 ANNE E HOLLAND COMMITTEE CHAIR UNTIL 5/19 2.00 X 0 0 0 ANNE SPERLING ASSEMBLY CHAIR 2.00 X 0 0 0 BRUCE D LEVY PRESIDENTIAL APPOINTEE UNTIL 5/19 2.00 X 0 0 0 CONNIE C HSIA ASSEMBLY CHAIR 2.00 X 0 0 0 DAVID LEWINSOHN PRESIDENTIAL APPOINTEE, CHAIR, IHC 2.00 X 0 0 0 DON HAYES CCR, PAST CHAIR UNTIL 5/19 2.00 X 0 0 0 ILONA JASPERS ASSEMBLY CHAIR 2.00 X 0 0 0 JAY K KOLLS ASSEMBLY CHAIR UNTIL 5/19 2.00 X 0 0 0 JENNIFER TREVOR CCR CHAIR 2.00 X 0 0 0 KARI LUTHER ROSBECK PAR CHAIR UNTIL 5/19 2.00 X 0 0 0 LYNN T TANOUE ASSEMBLY CHAIR UNTIL 5/19 2.00 X 0 0 0 MANOJ MAMMEN CCR CHAIR-ELECT 2.00 X 0 0 0 MICHELE MANION CHAIR, PAR 2.00 X 0 0 0 MICHELLE GONG ASSEMBLY CHAIR 2.00 X 0 0 0 PATRICK NANA-SINKAM ASSEMBLY CHAIR 2.00 X 0 0 0 PAUL E MOORE ASSEMBLY CHAIR UNTIL 5/19 2.00 X 0 0 0 RACHEL THOMSON ASSEMBLY CHAIR 2.00 X 0 0 0 RENEE D STAPLETON ASSEMBLY CHAIR UNTIL 5/19 2.00 X 0 0 0 RUXANA T SADIKOT CCR CHAIR UNTIL 6/18 2.00 X 0 0 0 SALLY SINGH ASSEMBLY CHAIR 2.00 X 0 0 0 SHARON DELL ASSEMBLY CHAIR 2.00 X 0 0 0 SONYE K DANOFF ASSEMBLY CHAIR 2.00 X 0 0 0 STEPHANIE JOAN LONDON ASSEMBLY CHAIR UNTIL 5/19 2.00 X 0 0 0 SUSAN J BARTLETT ASSEMBLY CHAIR 2.00 X 0 0 0 THEODORE F REISS PRESIDENTIAL APPOINTEE 2.00 X 0 0 0 TIM LAHM ASSEMBLY CHAIR 2.00 X 0 0 0 WANDA M GIBSON-SCIPIO ASSEMBLY CHAIR 2.00 X 0 0 0 YOLANDA N MAGETO PRESIDENTIAL APPOINTEE 2.00 X 0 0 0 KAREN COLLISHAW CHIEF EXECUTIVE DIRECTOR 40.00 X 425128 0 90319 PATRICIA HUIE CHIEF, FINANCIAL OFFICER 40.00 X 237768 0 52390 MICHELLE TURENNE CHIEF OF DEVELOPMENT 40.00 X 204694 0 54941 EILEEN LARSSON CHIEF PROGRAM OFFICER 40.00 X 202430 0 49391 STEPHEN ALTOBELLI CHIEF, OPERATIONS 40.00 X 200716 0 50891 KEVIN WILSON CHIEF, DOCUMENTS & PATIENT EDUCATION 40.00 X 270837 0 83424 DIANE GERN CHIEF, JOURNALS 40.00 X 197154 0 57910 GARY EWART CHIEF, ADVOCACY & GOVERNMENT RELATIONS 40.00 X 190920 0 55367 DORON BEN AVRAHAM SENIOR DIRECTOR, INFO STRATEGY 40.00 X 186741 0 40743 SHANE MCDERMOTT SENIOR DIRECTOR, ETHICS AND PROFESSIONALISM 40.00 X 175032 0 49464 2317664 0 584840 35 0 1 0 DARTMOUTH JOURNAL SERVICES PO BOX 419817 BOSTON MA 022419817 JOURNAL SERVICE 1096418 PSAV 23918 NETWORK PLACE CHICAGO IL 60673 AV SERVICES 371334 WYNDHAM JADE LLC PO BOX 840907 DALLAS TX 752840907 CONFERENCE SERVICES 305000 PUBLIQ GROUP INC 214 SULLIVAN STREET 6C NEW YORK NY 10012 MARTKETING/ADVERTISING 242315 DARTMOUTH PRINTING COMPANY PO BOX 419817 BOSTON MA 022419817 JOURNAL SERVICE 201566 13 20000 2304764 2324764 INTERNATIONAL CONFERENCE 541700 6850076 6850076 SCIENTIFIC JOURNAL 511120 5792601 4160301 1632300 MEMBERSHIP DUES 541700 4325078 4184609 140469 EDUCATIONAL PROGRAMS & WEBINARS 611710 779602 779602 17747357 396227 396227 1078941 1078941 11839357 10994678 844679 844679 844679 REBATES AND REFUNDS 900099 62504 62504 62504 22454472 16037092 1772769 2319847 X 1415840 1415840 100675 100675 1594911 917437 490939 186535 8850986 6589444 1993574 267968 323756 114459 197594 11703 1481267 540835 878529 61903 718829 280729 400044 38056 89856 12768 77088 166607 166607 33195 33195 219797 219797 4680161 4158742 408192 113227 174204 86241 80322 7641 554928 360188 177743 16997 813228 449061 328544 35623 1723706 673171 959280 91255 117391 73927 39321 4143 288145 115988 157203 14954 368124 249792 108053 10279 142007 55459 79030 7518 UNRELATED BUSINESS INCO 262310 262310 PUBLICATION EXPENSES 938560 938560 FEES 151094 100154 50940 BAD DEBT EXPENSE 125643 125643 183320 77312 89815 16193 25518540 17310782 7323763 883995 9024479 9210417 3806898 7510206 868027 501044 1083048 1091311 714280 547165 1777984 394444 1577697 1383540 26272088 26044362 3305371 3131404 381408 0 47033296 49419449 2147186 2663564 745000 785000 8163008 8255763 97280 95435 2268570 4319008 1618386 1838709 15039430 17957479 X 21729371 23258806 10264495 8203164 31993866 31461970 47033296 49419449 -3064068 2340111 192061 0 X 0 1 X 1 0 X 5212364 4252346 1737865 4438894 2324764 17966233 24698012 26528728 26592950 13746064 16034777 107600531 29910376 30781074 28330815 18184958 18359541 125566764 195942 1745010 1239365 2741018 1190328 7111663 0 195942 1745010 1239365 2741018 1190328 7111663 118455101 1070242 964203 1279631 1315915 1475168 6105159 1070242 964203 1279631 1315915 1475168 6105159 366869 908188 380818 1449058 907723 4012656 13886 20084 22899 7768447 7825316 31361373 32673549 30014163 28718378 20742432 143509895 0.82540 0.84050 0.04250 0.03610 X SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME: MEMBER LIST RENTAL - 2017 AMOUNT: $ 13,886. 2018 AMOUNT: $ 20,084. 2019 AMOUNT: $ 22,899. ACQUISTION OF ATS FOUNDATION - 2020 AMOUNT: $ 7,768,447. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1 1 0 1 21304 0 0 1 148228 0 0 169532 0 PART II-B, LINE 1: VOLUNTEERS - ATS COORDINATES AND SUPPORTS ATS MEMBERS CONTACTING MEMBERS OF CONGRESS AND EXECUTIVE AGENCIES TO SPEAK ON ISSUES THAT IMPACT PULMONARY, CRITICAL CARE, AND SLEEP MEDICINE. VOLUNTEER ACTIVITIES INCLUDE CONGRESSIONAL TESTIMONY, VISITING MEMBERS OF CONGRESS AND THEIR STAFF, MEETING WITH ADMINISTRATION OFFICIALS, AGENCY FIELD HEARINGS, AND COORDINATION WITH SISTER SOCIETIES. PAID STAFF - STAFF ENGAGE IN ADVOCACY ACTIVITIES INCLUDING CONGRESSIONAL TESTIMONY, VISITING MEMBERS OF CONGRESS AND THEIR STAFF, MEETING WITH ADMINISTRATION OFFICIALS, AGENCY FIELD HEARINGS, AND COORDINATION WITH SISTER SOCIETIES. MAILINGS - ATS SUBMITS MASS MAILINGS, MASS EMAILS, AND BLAST FAX TO CONGRESS TO ENSURE THEY ARE AWARE OF ATS' POSITIONS ON KEY LEGISLATIVE PRIORITIES. DIRECT CONTACT WITH LEGISLATORS, THEIR STAFF, GOVERNMENT OFFICIALS OR A LEGISLATIVE BODY - ATS MEMBERS AND STAFF MEET WITH OFFICIALS TO ADVOCATE FOR PULMONARY, CRITICAL CARE, AND SLEEP HEALTH. 0 1 X 263693 33884 500 297077 139760 100000 23933 263693 120275 19985 500 139760 120275 2546 2546 120275 120275 2585 2585 120275 0.74100 0.25900 0 0 1298159 180285 1117874 479825 214159 265666 1383540 DEFERRED LEASE BENEFIT 1838709 1838709 X 24574786 2340111 2340111 22234675 219797 219797 22454472 25298743 0 25298743 219797 219797 25518540 PART IV, LINE 2B: ATS COLLECTS DONATIONS AND MAKES DISBURSEMENTS FOR COSTS RELATED TO ITS AFFILIATED CHAPTERS PART V, LINE 4: THE INTENDED USE OF THE SOCIETY'S ENDOWMENT FUNDS ARE TO SUPPORT GRANTS AND TRAINING ASSOCIATED WITH THE SOCIETY'S VARIOUS PROGRAMS. PART X, LINE 2: ATS COMPLIES WITH THE PROVISIONS OF FASB ASC TOPIC 740, ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES, WHICH ADDRESSES THE DETERMINATION OF WHETHER TAX BENEFITS CLAIMED OR EXPECTED TO BE CLAIMED ON A TAX RETURN SHOULD BE RECORDED IN THE FINANCIAL STATEMENTS. MANAGEMENT EVALUATED ATS'S TAX POSITIONS AND CONCLUDED THAT ATS HAD TAKEN NO UNCERTAIN TAX POSITIONS THAT REQUIRE ADJUSTMENTS TO THE FINANCIAL STATEMENTS TO COMPLY WITH THE PROVISIONS OF THIS GUIDANCE. FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020, NO UNRECONGIZED TAX PROVISION OR BENEFIT EXISTS IN THE ACCOMPANYING FINANCIAL STATEMENTS. 1 EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICES EDITORS 5482 EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICES VIDEO PRODUCTION 9895 EAST ASIA AND THE PACIFIC 0 0 GRANTS AND AWARDS 25500 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 PROGRAM SERVICES EDITORS 178336 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 PROGRAM SERVICES MEMBERSHIP 26098 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 PROGRAM SERVICES LICENSE FEE 2450 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 PROGRAM SERVICES SUBSCRIPTION 1305 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 PROGRAM SERVICES SPONSORSHIP 2369 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 GRANTS AND AWARDS 1000 MIDDLE EAST AND NORTH AFRICA 0 0 GRANTS AND AWARDS 20000 NORTH AMERICA 0 0 PROGRAM SERVICES EDITORS 55346 NORTH AMERICA 0 0 PROGRAM SERVICES PATIENT EDUCATION 139965 NORTH AMERICA 0 0 GRANTS AND AWARDS 43215 SOUTH AMERICA 0 0 PROGRAM SERVICES CONFERENCE 3434 SOUTH AMERICA 0 0 GRANTS AND AWARDS 500 SOUTH ASIA 0 0 GRANTS AND AWARDS 2565 SUB-SAHARAN AFRICA 0 0 GRANTS AND AWARDS 7895 0 0 0 0 0 0 251435 273920 525355 TECHNICAL ASSISTANCE AND RESEARCH GRANT EAST ASIA AND THE PACIFIC 2 25500 CASH PAYMENT TECHNICAL ASSISTANCE GRANT EUROPE (INCLUDING ICELAND & GREENLAND) 2 1000 CASH PAYMENT RESEARCH GRANT MIDDLE EAST AND NORTH AFRICA 1 20000 CASH PAYMENT TECHNICAL ASSISTANCE AND RESEARCH GRANT NORTH AMERICA 4 43215 CASH PAYMENT TECHNICAL ASSISTANCE GRANT SOUTH AMERICA 1 500 CASH PAYMENT TECHNICAL ASSISTANCE GRANT SOUTH ASIA 2 2565 CASH PAYMENT TECHNICAL ASSISTANCE GRANT SUB-SAHARAN AFRICA 3 7895 CASH PAYMENT 0 0 0 0 0 0 PART I, LINE 2: THE ORGANIZATION REQUIRES A WRITTEN MID-POINT PROGRESS REPORT TO BE SUBMITTED BY THE RECIPIENT, BRIEFLY DESCRIBING THE RESEARCH CONDUCTED TO DATE, INDICATING THE CURRENT STAGE OF COMPLETENESS ACCORDING TO THE TIMELINE ORIGINALLY SUBMITTED WITH THE PROPOSAL, PROBLEMS ENCOUNTERED WITH THE PROGRESS OF THE STUDY IF ANY, AND EFFORTS MADE TO OVERCOME SUCH PROBLEMS. A FINAL REPORT IS DUE NO LATER THAN 30 DAYS AFTER THE INDICATED COMPLETION DATE OF THE PROJECT OUTLINING THE PROGRESS MADE IN ACCOMPLISHING THE PURPOSE OF THE GRANT. IN ADDITION, A ONE PAGE EXECUTIVE SUMMARY WRITTEN SPECIFICALLY FOR A NON-MEDICAL AUDIENCE IS INCLUDED WITH THE FINAL REPORT. THE SUMMARY INCLUDES A BRIEF BACKGROUND, STATEMENT OF THE PURPOSE OF THE STUDY, A BASIC DESCRIPTION OF THE METHODOLOGY, IMPORTANT FINDINGS, AND A CONCLUSION OR SUMMARY STATEMENT ABOUT THE RELEVANCE OF THE FINDINGS. THE RESEARCH IS SUBMITTED TO THE ORGANIZATION FOR PRESENTATION AT THE ANNUAL MEETING FOLLOWING COMPLETION OF THE STUDY. A FINAL FINANCIAL REPORT IS REQUIRED TO BE SUBMITTED 90 DAYS AFTER THE PROJECT END DATE. ALL UNEXPENDED FUNDS MUST BE RETURNED TO THE ORGANIZATION ALONG WITH THE FINAL ACCOUNTING REPORT. PAYMENTS FOR SUBSEQUENT GRANTS WILL BE CONTINGENT ON RECEIPT OF ANY OUTSTANDING FINAL ACCOUNTING REPORTS AND REFUNDS, AS APPLICABLE. PART I, LINE 3: ACCRUAL ACCOUNTING PART III, COL (C): ESTIMATED NUMBER OF RECIPIENTS IS BASED ON APPROVED AWARDS ACCEPTED. PART III ACCOUNTING METHOD: 1 TECHNICAL ASSISTANCE GRANTS 46 202600 0 RESEARCH GRANTS 58 1213240 0 PART I, LINE 2: THE ORGANIZATION REQUIRES A WRITTEN MID-POINT PROGRESS REPORT TO BE SUBMITTED BY THE RECIPIENT, BRIEFLY DESCRIBING THE RESEARCH CONDUCTED TO DATE, INDICATING THE CURRENT STAGE OF COMPLETENESS ACCORDING TO THE TIMELINE ORIGINALLY SUBMITTED WITH THE PROPOSAL, PROBLEMS ENCOUNTERED WITH THE PROGRESS OF THE STUDY IF ANY, AND EFFORTS MADE TO OVERCOME SUCH PROBLEMS. A FINAL REPORT IS DUE NO LATER THAN 30 DAYS AFTER THE INDICATED COMPLETION DATE OF THE PROJECT OUTLINING THE PROGRESS MADE IN ACCOMPLISHING THE PURPOSE OF THE GRANT. IN ADDITION, A ONE PAGE EXECUTIVE SUMMARY WRITTEN SPECIFICALLY FOR A NON-MEDICAL AUDIENCE IS INCLUDED WITH THE FINAL REPORT. THE SUMMARY INCLUDES A BRIEF BACKGROUND, STATEMENT OF THE PURPOSE OF THE STUDY, A BASIC DESCRIPTION OF THE METHODOLOGY, IMPORTANT FINDINGS, AND A CONCLUSION OR SUMMARY STATEMENT ABOUT THE RELEVANCE OF THE FINDINGS. THE RESEARCH IS SUBMITTED TO THE ORGANIZATION FOR PRESENTATION AT THE ANNUAL MEETING FOLLOWING COMPLETION OF THE STUDY. A FINAL FINANCIAL REPORT IS REQUIRED TO BE SUBMITTED 90 DAYS AFTER THE PROJECT END DATE. ALL UNEXPENDED FUNDS MUST BE RETURNED TO THE ORGANIZATION ALONG WITH THE FINAL ACCOUNTING REPORT. PAYMENTS FOR SUBSEQUENT GRANTS WILL BE CONTINGENT ON RECEIPT OF ANY OUTSTANDING FINAL ACCOUNTING REPORTS AND REFUNDS, AS APPLICABLE. X X X 0 0 0 0 0 0 0 0 0 KAREN COLLISHAW CHIEF EXECUTIVE DIRECTOR 425128 0 0 0 0 0 11250 0 79069 0 515447 0 0 0 KEVIN WILSON CHIEF, DOCUMENTS & PATIENT EDUCATION 270837 0 0 0 0 0 13000 0 70424 0 354261 0 0 0 PATRICIA HUIE CHIEF, FINANCIAL OFFICER 237768 0 0 0 0 0 0 0 52390 0 290158 0 0 0 MICHELLE TURENNE CHIEF OF DEVELOPMENT 204694 0 0 0 0 0 12330 0 42611 0 259635 0 0 0 DIANE GERN CHIEF, JOURNALS 197154 0 0 0 0 0 10488 0 47422 0 255064 0 0 0 EILEEN LARSSON CHIEF PROGRAM OFFICER 202430 0 0 0 0 0 7110 0 42281 0 251821 0 0 0 STEPHEN ALTOBELLI CHIEF, OPERATIONS 200716 0 0 0 0 0 12455 0 38436 0 251607 0 0 0 GARY EWART CHIEF, ADVOCACY & GOVERNMENT RELATIO 190920 0 0 0 0 0 12279 0 43088 0 246287 0 0 0 DORON BEN AVRAHAM SENIOR DIRECTOR, INFO STRATEGY 186741 0 0 0 0 0 9750 0 30993 0 227484 0 0 0 SHANE MCDERMOTT SENIOR DIRECTOR, ETHICS AND PROFESSI 175032 0 0 0 0 0 2719 0 46745 0 224496 0 0 0 FORM 990, PART VI, SECTION A, LINE 6 THE AMERICAN THORACIC SOCIETY HAS MEMBERS. FORM 990, PART VI, SECTION A, LINE 7A TWO MEMBERS OF THE BOARD OF DIRECTORS ARE APPOINTED AND THE REMAINDER ARE ELECTED BY MEMBERS. FORM 990, PART VI, SECTION B, LINE 11B THE 990 IS REVIEWED BY THE FINANCE DEPARTMENT FORM 990, PART VI, SECTION B, LINE 12C TRUSTEES, DIRECTORS, OFFICERS AND KEY EMPLOYEES ARE REQUIRED TO COMPLETE A CONFLICT OF INTEREST FORM ANNUALLY. ANY DISCLOSURES ARE INVESTIGATED. FORM 990, PART VI, SECTION B, LINE 15 IN ADDITION TO COMPARABILITY DATA, ATS ALSO EXAMINES FOR EACH POSITION, THE INTERNAL GRADE STRUCTURE, WHERE THE POSITION FALLS WITHIN THE GRADE STRUCTURE AND THE TENURE FOR THE POSITION. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART IX, LINE 11G TEMP AGENCY FEES: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 45,420. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 45,420. BUSINESS PROCESS CONSULTING: PROGRAM SERVICE EXPENSES 19,245. MANAGEMENT AND GENERAL EXPENSES 63,910. FUNDRAISING EXPENSES 62,461. TOTAL EXPENSES 145,616. CONTRACT SERVICES: PROGRAM SERVICE EXPENSES 1,176,191. MANAGEMENT AND GENERAL EXPENSES 39,182. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 1,215,373. EDITORIAL FEES: PROGRAM SERVICE EXPENSES 1,093,841. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 1,093,841. STIPENDS: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 233,403. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 233,403. ADVOCACY: PROGRAM SERVICE EXPENSES 56,782. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 56,782. CME DEVELOPMENT: PROGRAM SERVICE EXPENSES 873,398. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 873,398. COMMISSIONS AND DISCOUNTS: PROGRAM SERVICE EXPENSES 498,909. MANAGEMENT AND GENERAL EXPENSES 498. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 499,407. VIRTUAL SUPPORT: PROGRAM SERVICE EXPENSES 421,994. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 421,994. PROFESSIONAL SEARCH: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 25,512. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 25,512. GRAPHIC DESIGN: PROGRAM SERVICE EXPENSES 13,876. MANAGEMENT AND GENERAL EXPENSES 267. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 14,143. VIDEO AND MEDIA PRODUCTION: PROGRAM SERVICE EXPENSES 4,506. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 50,766. TOTAL EXPENSES 55,272. B - AMENDED RETURN THE TAX RETURN WAS AMENDED BECAUSE THE ORGINAL RETURN WAS FILED USING UNAUDITED DATA. THE TAX RETURN WAS AMENDED TO MATCH THE AUDITED FINANCIAL DATA. THE FOLLOWING LINES ON THE 990 HAVE BEEN UPDATED: PART I, LINES 7A, 7B, 8, 9, 10, 11, 12, 13, 16B, 17, 18, 19, 20, 21, AND 22 PART III, LINES 4A, 4B, 4C, 4D, 4E PART IV, LINES 11F AND 12A PART VIII, LINES 1E, 1F, 1H, 2A, 2B, 2C, 2D, 2G, 3, 5, 11A, 11B, 11E, AND 12 PART IX, LINES 2, 11G, 13, 14, 17, 19, 22, 24C, 24D, 24E, AND 25 PART X, LINES 1, 3, 4, 9, 11, 14, 15, 16, 17, 18, 19, 24, 26, 27, 28, 32, AND 33 PART XI, LINES 5 AND 8 PART XII, LINES 2B AND 2C SCHEDULE A, PART III, LINES 1, 2, 6, 7A, 7C, 8, 9, 10A, 10C, 11, 12, 13, 15, AND 17 SCHEDULE A, PART VI SCHEDULE B, PART I, LINES 2, 6, 8, 23, 24, 25, 26, 27, 28, AND 29 SCHEDULE D, PART V, LINES 1C, 1E, 1G, 2B, AND 2C SCHEDULE D, PART XI, LINES 1, 2A, 2E, 3, 4A, 4C, AND 5 SCHEDULE D, PART XII, LINES 1, 3, 4A, 4C, AND 5 SCHEDULE D, PART XIII SSCHEDULE I, PART III SCHEDULE O ALABAMA THORACIC SOCIETY 25 BROADWAY 4TH FLOOR NEW YORK NY 100042755 900814566 EDUCATION & RESEARCH AL 501(C)(6) N/A 0 ARIZONA THORACIC SOCIETY 25 BROADWAY 4TH FLOOR NEW YORK NY 100042755 454381827 EDUCATION & RESEARCH AZ 501(C)(6) N/A 0 COLORADO THORACIC SOCIETY 25 BROADWAY 4TH FLOOR NEW YORK NY 100042755 800659995 EDUCATION & RESEARCH CO 501(C)(6) N/A 0 CONNECTICUT THORACIC SOCIETY 25 BROADWAY 4TH FLOOR NEW YORK NY 100042755 821442659 EDUCATION & RESEARCH CT 501(C)(6) N/A 0 GEORGIA THORACIC SOCIETY 25 BROADWAY 4TH FLOOR NEW YORK NY 100042755 821470481 EDUCATION & RESEARCH GA 501(C)(6) N/A 0 HAWAII THORACIC SOCIETY 25 BROADWAY 4TH FLOOR NEW YORK NY 100042755 593843310 EDUCATION & RESEARCH HI 501(C)(6) N/A 0 INDIANA THORACIC SOCIETY 25 BROADWAY 4TH FLOOR NEW YORK NY 100042755 831957660 EDUCATION & RESEARCH IN 501(C)(6) N/A 0 LOUISIANA THORACIC SOCIETY 25 BROADWAY 4TH FLOOR NEW YORK NY 100042755 454437279 EDUCATION & RESEARCH LA 501(C)(6) N/A 0 METRO DC THORACIC SOCIETY 25 BROADWAY 4TH FLOOR NEW YORK NY 100042755 800759367 EDUCATION & RESEARCH DC 501(C)(6) N/A 0 MISSISSIPPI THORACIC SOCIETY 25 BROADWAY 4TH FLOOR NEW YORK NY 100042755 454560770 EDUCATION & RESEARCH MS 501(C)(6) N/A 0 NEW JERSEY THORACIC SOCIETY 25 BROADWAY 4TH FLOOR NEW YORK NY 100042755 900631066 EDUCATION & RESEARCH NJ 501(C)(6) N/A 0 NEW MEXICO THORACIC SOCIETY 25 BROADWAY 4TH FLOOR NEW YORK NY 100042755 364679463 EDUCATION & RESEARCH NM 501(C)(6) N/A 0 NEW YORK STATE THORACIC SOCIETY 25 BROADWAY 4TH FLOOR NEW YORK NY 100042755 800759359 EDUCATION & RESEARCH NY 501(C)(6) N/A 0 NORTH CAROLINA THORACIC SOCIETY 25 BROADWAY 4TH FLOOR NEW YORK NY 100042755 821364763 EDUCATION & RESEARCH NC 501(C)(6) N/A 0 OHIO THORACIC SOCIETY 25 BROADWAY 4TH FLOOR NEW YORK NY 100042755 371651271 EDUCATION & RESEARCH OH 501(C)(6) N/A 0 OKLAHOMA THORACIC SOCIETY 25 BROADWAY 4TH FLOOR NEW YORK NY 100042755 611666906 EDUCATION & RESEARCH OK 501(C)(6) N/A 0 OREGON THORACIC SOCIETY 25 BROADWAY 4TH FLOOR NEW YORK NY 100042755 454930900 EDUCATION & RESEARCH OR 501(C)(6) N/A 0 RHODE ISLAND THORACIC SOCIETY 25 BROADWAY 4TH FLOOR NEW YORK NY 100042755 611627263 EDUCATION & RESEARCH RI 501(C)(6) N/A 0 SOUTH CAROLINA THORACIC SOCIETY 25 BROADWAY 14TH FLOOR NEW YORK NY 100042755 821386624 EDUCATION & RESEARCH SC 501(C)(6) N/A 0 SOUTH DAKOTA THORACIC SOCIETY 25 BROADWAY 4TH FLOOR NEW YORK NY 100042755 821404679 EDUCATION & RESEARCH SD 501(C)(6) N/A 0 WASHINGTON THORACIC STATE SOCIETY 25 BROADWAY 4TH FLOOR NEW YORK NY 100042755 800759374 EDUCATION & RESEARCH WA 501(C)(6) N/A 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0